A Phase 2 Study of Oral Enzastaurin HCl in Patients With Metastatic Colorectal Cancer
Phase of Trial: Phase II
Latest Information Update: 10 Nov 2012
At a glance
- Drugs Enzastaurin (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 10 Nov 2012 Planned number of patients changed from 30 to 40.
- 06 Jun 2008 Primary endpoint added from ClinicalTrials.gov.